Voluntary announcement - first patient dose of CT0596 in china phase i registrational trial
Filed with HKEX · Stock code 2171 · · 2 pages · English
CARsgen Therapeutics Holdings Ltd. on 6ix
Earlier from CARsgen Therapeutics
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- List of directors and their roles and functions
- Resignation of non-executive director and non-compliance with rule 3.21 of the listing rules
- Voluntary announcement - first patient dose of CT1190B in china phase i registrational trial
- Interim report 2026
Follow CARsgen Therapeutics into a list and get an email when it puts out news.
Follow CARsgen Therapeutics